With an investment of around six million dollars, the future factory will offer three types of medicines in tablet format: paracetamol, coartem and enalapril.
This information was provided by Sérgio Sousa, president of the Board of Directors (PCA) of Ovihemba. Speaking at the clarification session about the recruitment of future workers, which began this Tuesday, the PCA pointed out that the pharmaceutical company Ovihemba wants to hire Angolan workers to enhance local human resources, as well as make Huambo an important reference in the manufacturing of medicines, accepted nationally and internationally.
Regarding the raw material, Sérgio Sousa, cited by Angop, said that, initially, the materials will come from Europe, as the factory will have a technical structure made up of production equipment, a modern laboratory and all the necessary conditions for a pharmaceutical industry, which will involve 32 employees (technical and administrative).
The company's PCA also said they were concerned about environmental issues, indicating that the factory has updated standards and meets environmental requirements to participate in the carbon reduction process: "We are concerned about climate issues and the future of future generations and we have than leaving a habitable planet for our grandchildren."
According to Sérgio Sousa, the manufacturing unit follows the standards of the World Health Organization (WHO) and has an infrastructure that relies on technological processes from Europe that are advisable to produce medicines that can be used to treat human beings.
Ataulfo de Fontes Pereira, vice-rector of the José Eduardo dos Santos University, applauded the pharmaceutical company's initiative, adding that the university offers courses in the health areas to meet the employment needs of this new manufacturing unit, in the process of being implemented in the province, writes Angop.
On the sidelines of the G20 summit, held in the Brazilian city of Rio de Janeiro, the President of the Republic, João Lourenço held several audiences with political figures from the fields of science and culture, high finance and the pharmaceutical industry.
According to a brief note from CIPRA, to which VerAngola had access, in the field of the pharmaceutical industry, João Lourenço met with the CEO of EMS Pharmaceutical Industrial Group, Carlos Eduardo Sánchez, having discussed "the possibility of extending its business to Angola".
Still with regard to the implementation of a pharmaceutical industry in the country, the Minister of Health, Sílvia Lutucuta, will travel to Brazil, at the beginning of next month, for an exploration and rapprochement visit, informed José de Lima Massano, Minister of State for the Economic Coordination, after the head of State's hearing with the EMS Pharmaceutical Industrial Group.
According to Lima Massano, following the visit of the national delegation to Brazil, in February, a delegation from the Brazilian company will go to Angola, to decide other aspects, with a view to the possible implementation of the project.
"We have this Brazilian group with this desire and with very concrete references from our reality, so there is a strong expectation here that we can have this group investing in our country", he said, quoted by Angop.
